PortfoliosLab logo
Arvinas, Inc. (ARVN)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US04335A1051

CUSIP

04335A105

IPO Date

Sep 27, 2018

Highlights

Market Cap

$556.92M

EPS (TTM)

-$0.66

Total Revenue (TTM)

$426.90M

Gross Profit (TTM)

$423.60M

EBITDA (TTM)

-$91.00M

Year Range

$5.94 - $37.38

Target Price

$22.42

Short %

10.76%

Short Ratio

2.92

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Arvinas, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-50.00%0.00%50.00%100.00%December2025FebruaryMarchAprilMay
-58.44%
93.25%
ARVN (Arvinas, Inc.)
Benchmark (^GSPC)

Returns By Period

Arvinas, Inc. (ARVN) returned -65.21% year-to-date (YTD) and -80.57% over the past 12 months.


ARVN

YTD

-65.21%

1M

4.71%

6M

-76.17%

1Y

-80.57%

5Y*

-33.99%

10Y*

N/A

^GSPC (Benchmark)

YTD

-4.26%

1M

11.24%

6M

-5.02%

1Y

8.55%

5Y*

14.02%

10Y*

10.31%

*Annualized

Monthly Returns

The table below presents the monthly returns of ARVN, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2025-8.14%0.51%-60.34%37.04%-30.67%-65.21%
20240.83%10.80%-10.22%-23.04%4.31%-19.67%3.34%-4.91%-5.85%7.31%1.10%-28.26%-53.43%
2023-4.21%-6.47%-10.86%-4.06%-16.71%13.70%-0.40%14.12%-30.38%-17.92%36.29%87.35%20.32%
2022-12.97%-9.34%3.84%-18.32%-24.16%0.96%26.18%-20.28%5.08%11.73%-17.44%-16.64%-58.35%
2021-11.17%3.79%-15.58%4.30%5.51%5.86%31.30%-14.73%-4.67%5.35%-12.67%8.64%-3.29%
202017.94%-2.74%-14.49%30.27%-36.63%0.81%-6.08%-17.62%-9.02%-11.44%15.73%250.95%106.69%
201935.49%11.20%-23.76%41.40%0.24%5.11%21.33%-2.51%-17.15%-4.13%85.87%7.01%219.77%
20185.11%-3.62%4.00%-24.01%-19.94%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of ARVN is 4, meaning it’s performing worse than 96% of other stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of ARVN is 44
Overall Rank
The Sharpe Ratio Rank of ARVN is 66
Sharpe Ratio Rank
The Sortino Ratio Rank of ARVN is 66
Sortino Ratio Rank
The Omega Ratio Rank of ARVN is 44
Omega Ratio Rank
The Calmar Ratio Rank of ARVN is 44
Calmar Ratio Rank
The Martin Ratio Rank of ARVN is 22
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Arvinas, Inc. (ARVN) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


The current Arvinas, Inc. Sharpe ratio is -0.94. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Arvinas, Inc. with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00December2025FebruaryMarchAprilMay
-0.95
0.44
ARVN (Arvinas, Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


Arvinas, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%December2025FebruaryMarchAprilMay
-93.82%
-8.35%
ARVN (Arvinas, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Arvinas, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Arvinas, Inc. was 94.26%, occurring on Apr 8, 2025. The portfolio has not yet recovered.

The current Arvinas, Inc. drawdown is 93.82%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-94.26%Jul 30, 2021927Apr 8, 2025
-64.42%May 12, 2020114Oct 21, 202037Dec 14, 2020151
-44.26%Jul 29, 201959Oct 18, 201918Nov 13, 201977
-39.71%Nov 9, 201830Dec 24, 201827Feb 4, 201957
-39.45%Feb 7, 202026Mar 16, 202029Apr 27, 202055

Volatility

Volatility Chart

The current Arvinas, Inc. volatility is 36.59%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%20.00%40.00%60.00%80.00%December2025FebruaryMarchAprilMay
36.59%
11.43%
ARVN (Arvinas, Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Arvinas, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Earnings Per Share

The chart presents the Earnings Per Share (EPS) performance of Arvinas, Inc., comparing actual results with analytics estimates. The company has exceeded analyst expectations for EPS in the past quarter, achieving a 217.6% positive surprise.


-3.00-2.00-1.000.001.002.0020212022202320242025
1.14
-0.97
Actual
Estimate

Valuation

The Valuation section provides an overview of how Arvinas, Inc. is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for ARVN relative to other companies in the Biotechnology industry. Currently, ARVN has a P/S ratio of 1.3. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for ARVN in comparison with other companies in the Biotechnology industry. Currently, ARVN has a P/B value of 0.9. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items